Dry eye syndrome can be a daily struggle, characterized by symptoms like irritation, burning, excessive tearing, and redness. Often, this discomfort is rooted in Meibomian Gland Dysfunction (MGD), where the glands in your eyelids fail to produce enough oil to keep your eyes lubricated.
Forma I is one half of the dynamic EnVision duo. It utilizes bipolar radiofrequency (RF) technology to specifically target the symptoms of dry eye disease caused by MGD. Here's how it works:
Lumecca I, unlike traditional IPL, stands out due to its higher light intensity. This intensified light penetrates deeper into the skin's layers, making it exceptionally effective for managing dry eye caused by inflammation, including ocular rosacea and demodex infestations. Lumecca I distinguishes itself from conventional IPL in several ways:
A single Lumecca I treatment can lead to a remarkable improvement in your skin. The best results typically manifest four to six weeks after treatment. Depending on your specific concerns, our experts may recommend a series of sessions spaced four to six weeks apart. Lumecca I treatments are quick, typically lasting from 15 to 30 minutes, depending on the target area and the severity of the condition. This makes the process straightforward and time-effective, even for the busiest of patients.
EnVision by InMode represents a significant leap in dry eye treatment. By addressing the underlying causes of dry eye and inflammation, it offers you a chance at lasting relief and an improved quality of life.
With Forma I and Lumecca I, we've enhanced our ability to provide you with a highly precise and effective solution for dry eye. We invite you to experience the future of dry eye care at Benjamin Eye Institute, where your eye health and comfort are our top priorities.

